Pablo Ruiz-Ocaña Selected Research

Pablo Ruiz-Ocaña Research Topics

3	Insulin Resistance 01/2023 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 11/2022
2	Inflammation (Inflammations) 01/2023 - 11/2022
2	Obesity 01/2023 - 11/2022
1	Metabolic Diseases (Metabolic Disease) 11/2022
1	Overweight 11/2022
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 11/2018
1	Costello Syndrome 11/2018
1	Arteriosclerosis 11/2018
1	Hypertriglyceridemia 11/2018
1	Dyslipidemias (Dyslipidemia) 11/2018
1	Brachydactyly 01/2018
1	Aggrecan Type Spondyloepimetaphyseal Dysplasia 01/2018
1	Osteochondritis Dissecans 01/2018
1	Kimberley Type Spondyloepiphyseal Dysplasia 01/2018

2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
2	AntioxidantsIBA 01/2023 - 01/2018
2	LipidsIBA 01/2023 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2018
1	Insulin (Novolin)FDA Link 01/2023
1	InflammasomesIBA 01/2023
1	PolyphosphatesIBA 11/2022
1	PolymersIBA 11/2022
1	Phosphates (Orthophosphate)IBA 11/2022
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 11/2018
1	Apolipoprotein C-II (ApoC2)IBA 11/2018
1	Lipoproteins (Lipoprotein)IBA 11/2018
1	Apolipoprotein A-VIBA 11/2018
1	Aggrecans (Aggrecan)IBA 01/2018